Chicago Sun-Times
with sports reporters Chris De Luca and Gordon Wittenmyer

Byrd suspended for drug violation

| No Comments | No TrackBacks

Former Cubs outfielder and All-Star Marlon Byrd has been suspended by Major League Baseball for violating the league's drug policy.
The league announced the action Monday.
Byrd was traded to the Boston Red Sox in May but was designated for assignment by the Red Sox on June 12.
Reports say the former Cub tested positive for the drug Tamoxifen, which is used in the treatment of breast cancer in women. It is an estrogen-blocking drug used most often to treat estrogen-related forms of breast cancer, but with powerful side effects.
The drug is said to be used to counter some of the sid effects of steroid use.
Byrd is a free agent but would face a 50 game suspension if he were to sign with a club.
Byrd released a statement through the Players Association saying he had taken ``a medication'' after suffering a recurrence of a non-baseball condition that had required surgery.
``I made an inexcusable mistake. Several years ago, I had surgery for a condition that was private and unrelated to baseball. Last winter I suffered a recurrence of that condition and I was provided with a medication that resulted in my positive test. Although that medication is on the banned list, I absolutely did not use it for performance enhancement reasons.
``I am mortified by my careless ness and I apologize to everyone who loves this game as I do. I will serve my suspension, continue to work hard and hope that I am given an opportunity to help a club win later this season.''

No TrackBacks

TrackBack URL: http://blogs.suntimes.com/cgi-bin/mt-tb.cgi/47978

Leave a comment

About this Entry

This page contains a single entry by Toni Ginnetti published on June 25, 2012 3:07 PM.

Rizzo Time! Top prospect makes Cub debut Tuesday vs. Mets was the previous entry in this blog.

Rizzo Already a ``Survivor'' is the next entry in this blog.

Find recent content on the main index or look in the archives to find all content.